Post-marketing surveillance analysis of human papillomavirus vaccine safety in Hebei province from 2018 to 2022

Post-marketing surveillance analysis of human papillomavirus vaccine safety in Hebei province from 2018 to 2022

ObjectiveTo analyze the characteristics of adverse events following immunization (AEFI) with human papillomavirus (HPV) vaccines in Hebei province from 2018 to 2022 and to evaluate the safety of these vaccines. MethodsAEFI cases following HPV vaccination in Hebei province from January 1, 2018, to De...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shifan WANG, Li SUN, Yafei WANG, Jinghui WANG, Jing LI, Yihan WANG, Qi LI
Format:	Article
Language:	zho
Published:	Editorial Office of Chinese Journal of Public Health 2025-04-01
Series:	Zhongguo gonggong weisheng
Subjects:	bivalent human papillomavirus vaccine quadrivalent human papillomavirus vaccine 9-valent human papillomavirus vaccine suspected adverse events following immunization hebei province
Online Access:	https://www.zgggws.com/article/doi/10.11847/zgggws1144008
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine in individuals aged 16–26 years in Chongqing, China
by: Yuan-yuan Zhang, et al.
Published: (2023-12-01)

Suspected adverse events following human papillomavirus vaccination in Ningbo city, 2018-2022: a surveillance data analysis
by: Shaoying ZHOU, et al.
Published: (2025-06-01)

Stability study of recombinant 9-valent human papillomavirus vaccine based on Escherichia coli expression system
by: Yuying Liu, et al.
Published: (2025-12-01)

Long-term effectiveness of the nine-valent human papillomavirus vaccine: Interim results after 12 years of follow-up in Scandinavian women
by: Susanne K. Kjaer, et al.
Published: (2024-12-01)

Human papillomavirus vaccine
by: Jacqui Souter
Published: (2013-10-01)

The indirect effect of the bivalent human papillomavirus vaccination program: an observational cohort study
by: Marit Middeldorp, et al.
Published: (2025-06-01)

Post-marketing surveillance for the safety of the quadrivalent human papillomavirus vaccine: a retrospective real-world study in China
by: Ruogu Meng, et al.
Published: (2025-12-01)

Vaccinal Prevention of the Diseases Caused by Human Papillomavirus: Evidence-Based Medicine. Review of Clinical Guidelines
by: Alexander A. Baranov, et al.
Published: (2017-06-01)

HPV vaccine knowledge and willingness to vaccinate among senior primary school students in Guangdong province, 2022: a cross-sectional survey
by: Li WU, et al.
Published: (2024-10-01)

Awareness regarding human papillomavirus and willingness for vaccination among college students with or without medical background in Guizhou Province
by: Qiongdan Hu, et al.
Published: (2024-12-01)

Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in preadolescence in the Netherlands
by: Birgit Sollie, et al.
Published: (2025-06-01)

Knowledge, attitude, and perception of the parents toward HPV vaccine administration to their children in Saudi Arabia: a cross-sectional study
by: Abubaker S. Bakhashab, et al.
Published: (2025-07-01)

Current Status of Vaccine of Human Papillomavirus-positive Patients with Oropharyngeal Carcinoma
by: Mohan Bansal
Published: (2024-01-01)

Integrative literature review on human papillomavirus vaccination recommendations in national immunization programs in select areas in the Asia-Pacific region
by: Wanatpreeya Phongsamart, et al.
Published: (2024-12-01)

Human papillomavirus vaccine uptake in South Korea
by: Jin Young Choi, et al.
Published: (2022-01-01)

What Are the Barriers to Human Papillomavirus Vaccination for Male in South Korea?
by: Sangrak Bae, et al.
Published: (2022-12-01)

Immunogenicity and duration of antibodies after vaccination with a two-dose series of the nine-valent human papillomavirus vaccine among Alaska Native children: a prospective cohort study
by: Jonathan Steinberg, et al.
Published: (2025-04-01)

Comparative effectiveness and immunogenicity of single-dose and multi-dose human papillomavirus vaccination: a systematic review
by: Meeyeong Jeong, et al.
Published: (2025-07-01)

HPV vaccination intention among guardians of female secondary school students in Chongqing, China
by: Ningpei Bai, et al.
Published: (2024-12-01)

Knowledge, Attitude, and Concerns of Saudi Parents Regarding Human Papillomavirus Vaccine
by: Ahmed A. Alsaati, et al.
Published: (2024-12-01)

Interconnectedness threat: unveiling the mechanisms behind human papillomavirus-induced cervical cancer
by: Racheal Ahuoyiza Ayeni, et al.
Published: (2025-03-01)

Acceptance of human papillomavirus vaccine among boys in Asia: A narrative review
by: Xiaoya Fu, et al.
Published: (2024-12-01)

Strategically striving to be more inclusive: A recommendation for gender-neutral human-papillomavirus vaccine policies
by: Mary Jue Xu, et al.
Published: (2025-12-01)

Human papillomavirus vaccine administration opportunities at well visits in adolescents
by: Kunal Saxena, et al.
Published: (2025-06-01)

Human papillomavirus vaccination at age 9 or 10 years to increase coverage – a narrative review of the literature, United States 2014–2024
by: Sarah K. Brewer, et al.
Published: (2025-12-01)

Overview of the Global Vaccination against Human Papillomavirus
by: Leyla S. Namazova-Baranova, et al.
Published: (2018-02-01)

Factors influencing HPV vaccination willingness among male college students in Jinan according to the health belief model
by: Yanrui Xu, et al.
Published: (2025-08-01)

Role of Human Papillomavirus Vaccination for Prevention of Male Infertility
by: Taeyong Park
Published: (2023-08-01)

Post-licensure safety monitoring of human papillomavirus vaccines in Jiangsu Province, China from 2019 to 2023
by: Ran Hu, et al.
Published: (2025-08-01)

Human papillomavirus vaccination hesitancy among young girls in Ethiopia: factors and barriers to uptake
by: Ashenafi Kibret Sendekie, et al.
Published: (2025-01-01)

Factors Related to Female Adolescent Parents’ Acceptance of the Human Papillomavirus Vaccine
by: Dora Samaria, et al.
Published: (2025-03-01)

Factors Associated with Acceptance of Vaccination Against Human Papillomavirus in eThekwini District of South Africa
by: Phelele Bhengu, et al.
Published: (2025-07-01)

Effect of information awareness on attitudes toward human papillomavirus vaccination intentions in Japan
by: Takayuki Takahashi, et al.
Published: (2025-01-01)

Otolaryngology practitioner attitudes toward human papillomavirus vaccination in academic otolaryngology clinics
by: Dante J. Merlino, et al.
Published: (2025-03-01)

Human papillomavirus vaccine uptake and its determinants among women in Africa: an umbrella review
by: Berihun Agegn Mengistie, et al.
Published: (2025-06-01)

The Human Papilloma Virus is a New Etiologic Factor in the Development of Cancer of the Head and Neck Organs. Problems and Prospects for their Solution
by: A. M. Mudunov
Published: (2018-10-01)

Cervical cancer in India and HPV vaccination
by: K Kaarthigeyan
Published: (2012-01-01)

Trends Towards Enhanced Rates and Sex Parity in HPV Vaccination in Croatia (2016–2023)
by: Lucija Raic, et al.
Published: (2025-04-01)

Comparative Analysis of HPV16 Variants in the Untranslated Regulatory Region, L1, and E6 Genes among Vaccinated and Unvaccinated Young Women: Assessing Vaccine Efficacy and Viral Diversity
by: Kahren van Eer, et al.
Published: (2024-08-01)

Assessing Saudi women’s awareness about human papillomavirus (HPV) and their susceptibility to receive the vaccine
by: Sana S. Alqarni, et al.
Published: (2024-12-01)